Clinical Trial: A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Prospective Randomized Controlled Trial of Evonail® Solution for Prevention or Treatment of Onycholysis in Breast Cancer Patients Who Received Neoadjuvant/Adjuvant Docetaxel Chemotherapy
Brief Summary: This study is a prospective randomized controlled study of EVONAIL® solution for prevention or treatment of onycholysis in patients with breast cancer receiving docetaxel chemotherapy.
Detailed Summary:
Sponsor: Samsung Medical Center
Current Primary Outcome: The incidence of onycholysis Gr 2 or more [ Time Frame: 12weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Samsung Medical Center
Dates:
Date Received: January 28, 2016
Date Started: August 2015
Date Completion:
Last Updated: April 26, 2017
Last Verified: April 2017